Beta-Adrenergic Blocking Agents (Topical) has 2 known drug interactions based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Dorzolamide Hydrochloride And Timolol Maleate Preservative Free, Timolol Maleate Ophthalmic Gel Forming Solution 0.25%. Patients taking Beta-Adrenergic Blocking Agents (Topical) should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Contraindicated
- 1
- Major
- 1
Contraindicated (1)
- Beta-Adrenergic Blocking Agents (Topical) + Dorzolamide Hydrochloride And Timolol Maleate Preservative Free— Concomitant use of two topical beta-adrenergic blocking agents is not recommended.
Major (1)
- Beta-Adrenergic Blocking Agents (Topical) + Timolol Maleate Ophthalmic Gel Forming Solution 0.25%— Concomitant use of two topical beta-adrenergic blocking agents is not recommended.